Get the Stockscreener App
31.51
1.68%
-0.5443
Indivior Plc stock is traded at $31.51, with a volume of 194.95K.
It is down -1.68% in the last 24 hours and up +38.63% over the past month.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
See More
Previous Close:
$32.05
Open:
$32.29
24h Volume:
194.95K
Relative Volume:
0.09
Market Cap:
$4.00B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
3,150.57
EPS:
0.01
Net Cash Flow:
$-383.00M
1W Performance:
+8.17%
1M Performance:
+38.63%
6M Performance:
+169.32%
1Y Performance:
+238.82%
1-Day Range:
$31.27
$32.42
1-Week Range:
$28.76
$32.42
52-Week Range:
$7.62
$32.42
Indivior Plc Stock (INDV) Company Profile
Name
Indivior Plc
Sector
Phone
804-379-1090
Address
234 BATH ROAD, SLOUGH, BERKSHIRE
Compare INDV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
31.50 | 4.00B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
120.02 | 53.10B | 9.40B | 2.65B | 2.22B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.58 | 42.93B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.3933 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.25 | 28.22B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
449.09 | 19.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Initiated | H.C. Wainwright | Buy |
| Jul-22-25 | Resumed | Jefferies | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-23-24 | Initiated | Piper Sandler | Overweight |
| Apr-03-24 | Initiated | Craig Hallum | Buy |
| Jul-13-23 | Initiated | Northland Capital | Outperform |
View All
Indivior Plc Stock (INDV) Latest News
Is Indivior PLC (2IVB) stock attractive post correction2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Can Indivior PLC stock reach $100 price targetTrade Ideas & Fast Moving Trade Plans - newser.com
Will Indivior PLC (2IVB) stock benefit from sector leadershipWeekly Trading Summary & Precise Swing Trade Entry Alerts - fcp.pa.gov.br
Using RSI to spot recovery in Indivior PLCWeekly Stock Report & Risk Managed Investment Strategies - newser.com
Why analysts upgrade Indivior PLC stockEarnings Risk Report & Reliable Volume Spike Alerts - newser.com
Here's Why Indivior Stock Soared 15% Today - MSN
Applying chart zones and confluence areas to Indivior PLCJuly 2025 Spike Watch & Precise Swing Trade Entry Alerts - newser.com
Does Indivior PLC show high probability of reboundQuarterly Investment Review & Free Reliable Trade Execution Plans - newser.com
Can Indivior PLC stock beat market expectations this quarterJuly 2025 Sentiment & Free Reliable Trade Execution Plans - newser.com
How Indivior PLC stock trades during market volatilityEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Is Indivior PLC stock bottoming outQuarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Is Indivior PLC stock attractive for income investorsPortfolio Value Summary & Accurate Buy Signal Alerts - newser.com
Indivior (INDV) Is Up 25.9% After Strong Q3 Results and Raised Revenue Guidance Has The Bull Case Changed? - simplywall.st
INDV Crosses Above Average Analyst Target - Nasdaq
Real time scanner hits for Indivior PLC explainedPortfolio Profit Report & Expert Verified Movement Alerts - newser.com
EBIT per share of Indivior PLC – LS:A3DWFC - TradingView
Indivior to pursue a change in domicile from the U.K. to the U.S - MSN
One-Year Outcomes of Real-World RECOVERâ„¢ Study Published in Jo - GuruFocus
Leading vs lagging indicators on Indivior PLC performance2025 Institutional Moves & Long-Term Safe Investment Ideas - newser.com
Monthly buprenorphine treatment shows lower relapse rates in OUD patients - Investing.com
Intraday pattern recognizer results for Indivior PLC2025 Risk Factors & Free Fast Entry Momentum Trade Alerts - newser.com
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine - PR Newswire
Indivior PLC’s Optimistic Earnings Call Highlights Growth - MSN
Will Indivior PLC stock deliver long term returnsPortfolio Value Report & Safe Swing Trade Setups - newser.com
Will Indivior PLC stock benefit from infrastructure spending2025 Stock Rankings & Scalable Portfolio Growth Ideas - newser.com
Indivior PLC 2025 Q3ResultsEarnings Call Presentation (NASDAQ:INDV) 2025-11-01 - Seeking Alpha
Indivior outlines $150M OpEx savings and raises 2025 revenue guidance to $1.22B as SUBLOCADE growth accelerates - MSN
Indivior PLC (INDV) Beats Q3 Earnings and Revenue Estimates - MSN
Indivior Plc Stock (INDV) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.49%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):